Vijayawada (Andhra Pradesh) [India], February 16 (ANI): The NTR Trust recently hosted a spectacular musical night, 'Euphoria, ...

VIJAYAWADA: Minister for IT Nara Lokesh lauded the NTR Trust for its unwavering commitment to social service at its ...

Andhra Pradesh Deputy Chief Minister Pawan Kalyan announced a donation of 50 lakhs to the NTR Trust during the NTR Trust ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Discover Agios Pharmaceuticals' Q4 2024 earnings highlights, growth plans for Pyrukynd in thalassemia & sickle cell, and insights on safety, clinical ...

Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and ...

Cash, cash equivalents and marketable securities as of December 31, 2024, were $1.5 billion compared to $806.4 million as of December 31, 2023.

An estimated 12,000 children are born with thalassemia major, a severe form of the disease, in India each year, accounting ...

After a decade of relying on blood transfusions for her congenital disorder, 11-year-old Dang Thanh Mai Thu is now recovering ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

There were no serious adverse events or treatment-related mortalities. Evidence Rating Level: 2 (Good) Study Rundown: ...

Two mechanisms are responsible for iron overload in β-thalassemia: increased iron absorption due to ineffective erythropoiesis and blood transfusions. This review examines the mechanisms of myocardial ...